Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities
Launched by UNIVERSITY OF COLORADO, DENVER · Aug 4, 2022
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial, called "Advancing Rehabilitation Paradigms for Older Adults in Skilled Nursing Facilities," is studying whether high-intensity rehabilitation can help older adults recover better after being hospitalized and admitted to skilled nursing facilities. The goal is to see if this type of rehabilitation can be effectively used to improve patients' ability to move and perform daily activities. Researchers also want to understand what makes it easier for these facilities to adopt new rehabilitation practices successfully.
To participate in this trial, individuals need to be at least 50 years old and admitted to a skilled nursing facility from the hospital, where they can walk when they arrive. However, people with certain medical conditions or restrictions on physical activity may not be eligible. If you or a loved one joins this study, you can expect to work with rehabilitation staff who will guide you through the process and monitor your progress. This trial is currently recruiting participants and aims to provide important insights that could enhance rehabilitation for older adults in the future.
Gender
ALL
Eligibility criteria
- • Rehabilitation staff at enrolled sites will participate in research activities, as indicated by group assignment.
- Site Inclusion Criteria:
- • Aegis Therapies-contracted skilled nursing facility (SNF)
- • Admits approximately 15 patients per month for short term rehabilitation
- Patient Inclusion Criteria:
- • At least 50 years of age
- • Admitted to a SNF from the hospital
- • Ambulatory upon SNF admission
- Patient Exclusion Criteria:
- • Contraindications to high-intensity resistance training, per American College of Sports Medicine Exercise Testing and Prescription
- • Lower extremity weight-bearing precautions
- • Neurological diagnosis (e.g., Cerebral vascular accident, Multiple Sclerosis, Parkinson's disease)
- • Subsequent SNF admission
About University Of Colorado, Denver
The University of Colorado, Denver, is a leading academic institution dedicated to advancing medical research and improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university conducts a diverse range of clinical trials aimed at addressing critical health challenges. Its research initiatives are supported by a multidisciplinary team of experts, state-of-the-art facilities, and a commitment to ethical standards and patient safety. By fostering partnerships with local and global communities, the University of Colorado, Denver, strives to translate scientific discoveries into meaningful advancements in clinical practice and public health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Aurora, Colorado, United States
Frisco, Texas, United States
Patients applied
Trial Officials
Jennifer Stevens-Lapsley, PhD
Principal Investigator
University of Colorado, Denver
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials